Evolent Health Pre-Tax Profit Margin 2014-2025 | EVH
Evolent Health Pre-Tax Profit Margin Historical Data | |||
---|---|---|---|
Date | TTM Revenue | TTM Pre-Tax Income | Pre-Tax Margin |
2025-03-31 | $2.40B | $-0.11B | -4.59% |
2024-12-31 | $2.56B | $-0.06B | -2.50% |
2024-09-30 | $2.46B | $-0.09B | -3.57% |
2024-06-30 | $2.35B | $-0.10B | -4.04% |
2024-03-31 | $2.18B | $-0.13B | -6.02% |
2023-12-31 | $1.96B | $-0.20B | -10.29% |
2023-09-30 | $1.79B | $-0.16B | -9.16% |
2023-06-30 | $1.63B | $-0.18B | -10.78% |
2023-03-31 | $1.48B | $-0.15B | -9.78% |
2022-12-31 | $1.35B | $-0.06B | -4.51% |
2022-09-30 | $1.22B | $-0.05B | -3.94% |
2022-06-30 | $1.09B | $-0.02B | -1.66% |
2022-03-31 | $0.99B | $-0.02B | -2.33% |
2021-12-31 | $0.91B | $-0.03B | -3.31% |
2021-09-30 | $0.91B | $-0.04B | -4.75% |
2021-06-30 | $0.92B | $-0.07B | -7.25% |
2021-03-31 | $0.92B | $-0.26B | -28.73% |
2020-12-31 | $0.93B | $-0.33B | -35.78% |
2020-09-30 | $0.76B | $-0.55B | -72.19% |
2020-06-30 | $0.74B | $-0.54B | -72.79% |
2020-03-31 | $0.71B | $-0.36B | -50.70% |
2019-12-31 | $0.69B | $-0.33B | -48.18% |
2019-09-30 | $0.80B | $-0.13B | -15.57% |
2019-06-30 | $0.73B | $-0.11B | -15.01% |
2019-03-31 | $0.69B | $-0.09B | -12.99% |
2018-12-31 | $0.63B | $-0.05B | -8.61% |
2018-09-30 | $0.55B | $-0.05B | -9.85% |
2018-06-30 | $0.51B | $-0.06B | -11.26% |
2018-03-31 | $0.47B | $-0.07B | -14.29% |
2017-12-31 | $0.44B | $-0.08B | -17.47% |
2017-09-30 | $0.41B | $-0.09B | -22.49% |
2017-06-30 | $0.36B | $-0.09B | -25.76% |
2017-03-31 | $0.31B | $-0.09B | -27.33% |
2016-12-31 | $0.25B | $-0.24B | -93.31% |
2016-09-30 | $0.21B | $-0.22B | -102.36% |
2016-06-30 | $0.19B | $-0.22B | -113.54% |
2016-03-31 | $0.15B | $0.18B | 124.14% |
2015-09-30 | $0.03B | $0.35B | 1176.67% |
2014-12-31 | $0.00B | $-0.03B | 0.00% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Information Systems | $1.086B | $2.555B |
Evolent Health, Inc. is involved in the healthcare delivery and payment markets. The company provides technology-enabled services platform for providers to transition their organization in value-based payment models. Evolent Health, Inc. is based in Arlington, Virginia. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Veeva Systems (VEEV) | United States | $45.769B | 58.23 |
Hims & Hers Health (HIMS) | United States | $14.374B | 149.35 |
Tempus AI (TEM) | United States | $11.826B | 0.00 |
Doximity (DOCS) | United States | $10.774B | 49.88 |
IRhythm Technologies (IRTC) | United States | $4.653B | 0.00 |
Inspire Medical Systems (INSP) | United States | $3.861B | 60.33 |
Hinge Health (HNGE) | United States | $3.282B | 0.00 |
Privia Health (PRVA) | United States | $2.664B | 182.08 |
Enovis (ENOV) | United States | $1.720B | 9.59 |
Phreesia (PHR) | United States | $1.560B | 0.00 |
Clover Health Investments (CLOV) | United States | $1.537B | 0.00 |
Schrodinger (SDGR) | United States | $1.501B | 0.00 |
Azenta (AZTA) | United States | $1.357B | 63.06 |
10x Genomics (TXG) | United States | $1.331B | 0.00 |
Omnicell (OMCL) | United States | $1.313B | 23.17 |
Claritev (CTEV) | United States | $0.657B | 0.00 |
Fulgent Genetics (FLGT) | United States | $0.595B | 0.00 |
Butterfly Network (BFLY) | United States | $0.514B | 0.00 |
Veradigm (MDRX) | United States | $0.487B | 0.00 |
Talkspace (TALK) | United States | $0.448B | 134.00 |
Standard BioTools (LAB) | United States | $0.399B | 0.00 |
TruBridge (TBRG) | United States | $0.337B | 746.67 |
Outset Medical (OM) | United States | $0.336B | 0.00 |
Nyxoah SA (NYXH) | Belgium | $0.263B | 0.00 |
Health Catalyst (HCAT) | United States | $0.251B | 0.00 |
SOPHiA GENETICS SA (SOPH) | Switzerland | $0.203B | 0.00 |
KORU Medical Systems (KRMD) | United States | $0.156B | 0.00 |
EUDA Health Holdings (EUDA) | Singapore | $0.138B | 0.00 |
CareCloud (CCLD) | United States | $0.106B | 4.03 |
Pulmonx (LUNG) | United States | $0.105B | 0.00 |
American Well (AMWL) | United States | $0.105B | 0.00 |
MDxHealth SA (MDXH) | Belgium | $0.094B | 0.00 |
111 (YI) | China | $0.069B | 0.00 |
HeartBeam (BEAT) | United States | $0.051B | 0.00 |
ImmunoPrecise Antibodies (IPA) | Canada | $0.046B | 0.00 |
P3 Health Partners (PIII) | United States | $0.045B | 0.00 |
Zhongchao (ZCMD) | China | $0.037B | 0.00 |
Zepp Health (ZEPP) | Netherlands | $0.035B | 0.00 |
Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
Precipio (PRPO) | United States | $0.017B | 0.00 |
Bullfrog AI Holdings (BFRG) | United States | $0.016B | 0.00 |
Healthcare Triangle (HCTI) | United States | $0.012B | 0.00 |
MSP Recovery (MSPR) | United States | $0.010B | 0.00 |
Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
Movano (MOVE) | United States | $0.005B | 0.00 |
HeartSciences (HSCS) | United States | $0.004B | 0.00 |
Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
Evaxion - (EVAX) | Denmark | $0.003B | 0.00 |
Future Health ESG (FHLT) | United States | $0.000B | 0.00 |